Table 1.
Acceptance rate of testicular prostheses in unselected cohort of GCT patients
| Total | With prosthesis | ||
|---|---|---|---|
| n (%) | n (%) | 95% CI | |
| Total sample | 475 (100) | 128 (26.9) | 23.0%; 31.2% |
| Histology* | |||
| Seminoma | 293 (100) | 81 (27.6) | 22.6%; 33.1% |
| Nonseminoma | 182 (100) | 47 (25.8) | 19.6%; 32.8% |
| Clinical stage** | |||
| CS1 | 313 (100) | 91 (29.1) | 24.1%; 24.4% |
| CS 2 | 138 (100) | 32 (23.2) | 16.4%; 31.1% |
| CS 3 | 24 (100) | 5 (20.8) | 7.1%; 42.2% |
| Age at diagnosis § | |||
| ≤20 years | 16 (100) | 4 (25.0) | 7.3%; 52.2% |
| >20 - ≤ 30 years | 103 (100) | 34 (33.0) | 24.1%; 43.0% |
| >30 - ≤ 40 years | 206 (100) | 61 (29.6) | 23.5%; 36.4% |
| >40 - ≤ 50 years | 113 (100) | 25 (22.1) | 14.9%; 30.9% |
| >50 - ≤ 60 years | 37 (100) | 4 (10.8) | 3.0%; 25.4% |
| Treatment # | |||
| 1997 - 2003 | 143 (100) | 35 (24.5) | 17.7%; 32.4% |
| 2004 – 2009 | 167 (100) | 55 (32.9) | 25.9%; 40.6% |
| 2010 – 2014 | 165 (100) | 38 (23.0) | 16.8%; 30.2% |
*histology: chi-square test p = 0.66.
**clinical stage: Cochran-Armitage Trend Test p = 0.07.
§age at diagnosis: Cochran-Armitage Trend Test p = 0.006, significant.
#episode of treatment: Cochran-Armitage Trend Test p = 0.38.
CI 95% confidence intervals.